|
ROZA |
IRYS |
|
08:00-09:00 |
Registration |
|
09:00-10:00 |
ESMI Plenary Lecture 3
New probe-based strategies for quantitative microscopy of signaling dynamics in single cells
Theodorus Gadella (Amsterdam, The Netherlands)
Co-Chairs: Vasilis Nziachristos (Munich, Germany), Bengt Långström (Uppsala, Sweden) (TBC) |
|
10:00-10:30 |
Coffee break & Exhibition |
|
10:30-12:00 |
Parallel Session 5: Neuroscience II
Co-Chairs: Markus Rudin (Zürich, Switzerland), Veerle Baekelandt (Leuven, Belgium), Mathias Hoehn (Cologne, Germany) |
Parallel Session 6: Cardiovascular I (together with ESR)
Co-Chairs: Tony Lahoutte (Mons, Belgium), Nicolas Grenier (Bordeaux, France) |
|
10:30-10:45 |
Potential to use transgenic animals for imaging of neurological diseases
Ludwig Aigner (Salzburg, Austria) |
Potentials of new contrast agents for vascular molecular imaging in patients
Philippe Douek (Lyon, France) |
|
10:45-11:00 |
Specific cell labeling by in vivo viral infection with imaging reporters: the challenges
Veerle Baekelandt (Leuven, Belgium) |
Protease specific nanosensors in atherosclerosis
Eyk Schellenberger (Berlin, Germany) |
|
11:00-11:15 |
YIA Applicant's Presentation: Optimization of an mri method to measure microvessel density: application to monitor angiogenesis after stroke, Philipp Boehm-Sturm (Cologne, Germany) |
YIA Applicant's Presentation: Imaging of inflamed carotid artery atherosclerotic plaques with the use of 99mtc-hynic-il-2 scintigraphy in the end-stage renal disease patients, Marta Opalinska (Krakow, Poland) |
|
11:15-11:30 |
Mri study of intra-arterial bone marrow-derived macrophage administration after acute focal ischemic stroke in rats, Adrien Riou (Lyon, France) |
Uptake of 68ga-chloride in atherosclerotic plaques of ldlr-/-apob100/100mice, Johanna Silvola (Turku, Finland) |
|
11:30-11:45 |
YIA Applicant's Presentation: Inactivated paramagnetic tissue plasminogen activator predicts thrombolysis outcome following stroke, Maxime Gauberti (Caen, France) |
YIA Applicant's Presentation: Hybrid imaging using dual energy µct and fmt for characterization of atherosclerotic plaques in apoe -/- mice, Felix Gremse (Aachen, Germany) |
|
11:45-12:00 |
Matrix metalloproteinase-9 - a possible therapeutic target in intractable epilepsy, Grzegorz Wilczynski (Warsaw, Poland) |
YIA Applicant's Presentation: Long circulating emulsion based ct contrast agents, Anke De Vries (Eindhoven, Netherlands) |
|
12:00-13:00 |
Lunch Break |
|
13:00-14:30 |
Parallel Session 7: Probes II (together with EANM)
Co-Chairs: Frédéric Dollé (Orsay, France), Denis Guilloteau (Tours, France) |
Parallel Session 8: Gene & cell based Therapies (together with Clinigene)
Co-Chairs: Ludwig Aigner (Salzburg, Austria), NN (Clinigene), Cornel Fraefel (Zürich, Switzerland) |
|
13:00-13:15 |
Application of microfluidics to the ultra-rapid preparation of fluorine-18 and carbon-11 labelled compounds
Philip Miller (London, UK) |
Everything but not cell replacement with neural stem cell transplants,
Stefano Pluchino (Milano, Italy)
|
|
13:15-13:30 |
Radioligand for in vivo measuring neurotransmitters release
Christer Halldin (Stockholm, Sweden) |
Mesenchymal Stem Cell Transplantation: An Option to Promote Remyelination?
Ludwig Aigner (Salzburg, Austria) |
|
13:30-13:45 |
18F-tracers for Amyloid plaques
Denis Guilloteau (Tours, France) |
Viral vector-mediated transcriptional targeting of dendritic cells for antigen-specific tolerance induction in EAE/MS
Christiane Dresch (Zürich, Switzerland) |
|
13:45-14:00 |
YIA Applicant's Presentation: Chelators for radiocopper: biological/pharmacokinetic differences of [tyr3,thr8]octreotide conjugates, Abiraj Keelara (Basel, Switzerland) |
Delivery of a bioluminescent transgene to a tumor via bone marrow engraftment and local control of gene expression by non invasive local hyperthermia, Pierre-Yves Fortin (Bordeaux, France) |
|
14:00-14:15 |
[11c]somadam: potential sert ligand for pet studies and comparison with [11c]madam, Fabienne Gourand (Caen, France) |
YIA Applicant's Presentation: Dendritic cell labelling with paramagnetic nanoparticles and 111in-oxine for in vivo magnetic resonance imaging and scintigraphic imaging, Cristina Martelli (Milan, Italy) |
|
14:15-14:30 |
Mr imaging of extracellular redox by a thiolsensitive gd(iii)-do3a derivative, Valeria Menchise (Torino, Italy) |
YIA Applicant's Presentation: The type 2 cannabinoid receptor as a new pet reporter gene for the brain, Caroline Vandeputte (Leuven, Belgium) |
|
14:30-16:00 |
Guided Poster Session2 with Coffee break |
|
14:30-16:00 |
Poster Walk 5: Imaging in Cancer & Drug Development
(P013-P030)
Co-Chairs:
Peter Brader (Graz, Austria)
Nicolas Grenier (Bordeaux, France) |
Poster Walk 6: Imaging in Other Diseases
(P031-P033) & (P079-P091)
Co-Chairs:
Bertrand Tavitian (Orsay, France)
John Clark (Edinburgh, UK) |
Poster Walk 7: Imaging-guided Gene and Cell based and Targeted Therapies
(P048-P057) & (P092-P096)
Co-Chairs:
Ludwig Aigner (Salzburg, Austria)
Adriana Maggi (Milano, Italy) |
|
16:00-17:00 |
ESMI Plenary Lecture 4
Roza & Irys
Molecular Imaging of CXCR4 Receptors
Hans Jürgen Wester (Munich, Germany)
Co-Chairs: Adriana Maggi (Milano, Italy), Adriaan Lammertsma (Amsterdam, The Netherlands) |
|
17:00-18:00 |
Plenary Session on Current Contribution of Imaging Technologies to Drug Development
Roza & Irys
Co-Chairs: Adriana Maggi (Milano, Italy), Adriaan Lammertsma (Amsterdam, The Netherlands) |
|
17:00-17:15 |
Evaluation of the temporal window for drug delivery following ultrasound mediated membrane permeability enhancement, Matthieu Lepetit-Coiffe (Bordeaux, France) |
|
17:15-17:30 |
Integrisense: a novel near-infrared fluorescent probe for avb3 integrin and its applications in drug discovery, Cyrille Sur, Merck Research Laboratories (Westpoint, USA) |
|
17:30-17:45 |
Harnessing the Power of Bioluminescence to Cross the In Vitro–In Vivo Divide, John Watson, PROMEGA (Madison, Wisconsin, USA) |
|
17:45-18:00 |
In vivo imaging in drug discovery: the example of application in the development of novel estrogenic compounds, Andrea Biserni, TOP Srl (Milano, Italy) |